Helen Swaisland

49 papers and 6.2k indexed citations i.

About

Helen Swaisland is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Helen Swaisland has authored 49 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 18 papers in Molecular Biology. Recurrent topics in Helen Swaisland’s work include PARP inhibition in cancer therapy (20 papers), HER2/EGFR in Cancer Research (13 papers) and Colorectal Cancer Treatments and Studies (11 papers). Helen Swaisland is often cited by papers focused on PARP inhibition in cancer therapy (20 papers), HER2/EGFR in Cancer Research (13 papers) and Colorectal Cancer Treatments and Studies (11 papers). Helen Swaisland collaborates with scholars based in United Kingdom, United States and The Netherlands. Helen Swaisland's co-authors include Stan B. Kaye, James Carmichael, Jan H.M. Schellens, David S. Boss, Johann S. de Bono, Peter G. Mortimer, Alan Ashworth, Timothy A. Yap, Peter C.C. Fong and Alan Lau and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Co-authorship network of co-authors of Helen Swaisland i

Fields of papers citing papers by Helen Swaisland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Swaisland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Swaisland. The network helps show where Helen Swaisland may publish in the future.

Countries citing papers authored by Helen Swaisland

Since Specialization
Citations

This map shows the geographic impact of Helen Swaisland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Swaisland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Swaisland more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2025